"TO THRIVE AS A FIELD, DIGITAL MEDICINE REQUIRES AN UNPRECEDENTED LEVEL OF INTERDISCIPLINARY COLLABORATION. FROM REGULATORS TO WHITE-HAT HACKERS, ETHICISTS TO ENGINEERS, AND CLINICIANS TO CITIZEN SCIENTISTS, NEW COOPERATIVE NETWORKS MUST EMERGE TO ENSURE THAT DIGITAL MEDICINE REALIZES ITS FULL POTENTIAL TO IMPROVE HUMAN HEALTH." (DIGITAL MEDICINE SOCIETY)
Building off of recent advancements in the field, the Digital Implementation Forum focuses on ways for life sciences to take advantage of new opportunities within digital health and digital measurement; as well as how these new data can supplement existing collection strategies to drive research forward. Be a part of the movement to get these validated digital measures and digital health tools (DHTs) into the hands of patients, their physicians and caregivers.

Join 30+ speakers, 125+ senior-level pharma, clinical trials, technology and digital health executives this November 8, 2023 at Pfizer in Cambridge to learn, network, develop and improve the way digital health measurement tools are being created, standardized, scaled and deployed in life sciences to improve data quality, improve patient experience & accelerate drug development.
Location
Pfizer Innovation Research (PfIRe Lab)
1 Portland St
Cambridge, MA 02139
Date & Time
November 8, 2023
9:00am - 5:30pm
CORE THEMES:

1. The Winding Road to Novel Digital Endpoints: Successes and Failures
2. Let's Be Honest - All Roses Have Thorns: Validation, Pitfalls, Proving Value and Ease of Use - How ClinOps can Effectively scale
3. Transitioning from a Clinical Trial Endpoint to Use as a Clinical Tool / Digital Therapeutic
4. Reimbursement & Utilization - Evidence Generation: Discussions with Patients, Advocates, HCPs and Payers
November 8, 2023
8:00 AM

Registration, Coffee and Conversation
Conference registration open with continental breakfast and coffee served

9:00 AM

Opening Remarks from Conference Chair

Carrie Northcott, Head of Digital Sciences, Pfizer

9:15 AM

The Winding Road to Novel Digital Endpoints

What wakes you up in the morning? Successes & failures
9:15 AM

Operations and the Art of the Possible

Jonathan Bruno, Director, Project Management, Pfizer

9:30 AM

Remote and Continuous Assessment of Exercise Capacity in Pulmonary Arterial Hypertension with a Wrist-Worn Accelerometer

Dzmitry Kaliukhovich, Principal Data Scientist, Data Science & Digital Health, Johnson & Johnson Innovative Medicine

9:45 AM

Developing a Wearable-Based Digital Biomarker for Sweat Detection in relation to Fabry Disease

Matteo Lai, CEO, Empatica
Ariel Dowling, Head, Sensing and Measurement, Takeda

10:05 AM

Panel Discussion: The Latest Successes and Failures of Digital Endpoints
 
Tim McCarthy, VP, Head of Digital Sciences & Translational Imaging, Pfizer
Rinol Alaj, Head of Digital Health Technologies, Regeneron
Gayle Wittenberg, VP Neuroscience Data Science & Digital Health, Johnson & Johnson Innovative Medicine

Led by Xuemei Cai, Sr. Director, Head of Clinical Research, Pfizer
10:30 AM

NETWORKING COFFEE BREAK

11:00 AM

Let's All be Honest: All Roses Have Thorns!

Validation, Pitfalls, Proving Value and Ease of Use of Digital Tools
Candid discussion around implementation pain points: practicality vs. value add
11:00 aM

Using a Wearable Patch to Develop a Digital Monitoring Biomarker of Inflammation in Response to LPS Challenge

Meenakshi Chatterjee, Principal Scientist, Data Science & Digital Health, Johnson & Johnson Innovative Medicine

11:15 aM

Transforming Clinical Trials: Digital Measures, Regulatory Hurdles, and Strategic Collaborations

Jeremy Wyatt, CEO, ActiGraph

11:30 aM

Enabling Efficient, Large-Scale Cloud-Based Processing of Unstructured Clinical Trial Data

Yiorgos Christakis, Senior Data Scientist, Pfizer
Lukas Adamowicz, Senior Data Scientist, Pfizer

11:45 aM

Optimization of Digital Tools: Connectivity and Compliance

Kenzie Carlson, Implementation Manager, Digital Strategy, Takeda

12:00 PM

PANEL DISCUSSION: All Roses Have Thorns - but how can we limit the number of times we learn the hard way?

Kenzie Carlson, Implementation Manager, Digital Strategy, Takeda
Nikolay Manyakov, Sr. Director, Data Science & Digital Health, Johnson & Johnson Innovative Medicine
Matteo Lai, CEO, Empatica

Led by Charmaine Demanuele, Executive Director, Head of Quantitative Sciences, Pfizer

12:25 PM

NETWORKING LUNCHEON

1:20 PM

Transitioning Digital Measures from a Clinical Trial Endpoint to Use as a Clinical/Diagnostic Tool or Digital Therapeutic

Why do we care? What is the value add?
Differences in regulatory pathways - FDA paths to move forward
Translation to other diseases, as well as severities and ethnicities
1:20 PM

Clinical Trial Case Studies:  AI/ML-based Clinical Tools at the Point of Care

Chris Economos, VP of Life Science, Eko Health
Caroline Currie, VP of Clinical, Eko Health

1:40 PM

Proposed Global Standard Schema for Decentralized Clinical Trials as a Care Option Leveraged with Hospitals at Home

Maria Palombini, Global Practice Leader, Healthcare & Life Sciences, IEEE

1:50 PM

Precision Digital Therapeutics in Schizophrenia

Abhishek Pratap, Sr. Clinical Program Leader, Boehringer Ingelheim

2:05 PM

PANEL DISCUSSION: Transitioning from a Clinical Trial Endpoint to Wider Use as a Clinical Tool / Digital Therapeutic

Bryan Hansen, Director, Data Science & Digital Health, Neuroscience, Johnson & Johnson Innovative Medicine
Abhishek Pratap, Sr. Clinical Program Leader, Boehringer Ingelheim
Andrea Coravos, CEO, HumanFirst
Laura Taraboanta, Associate Director, Clinical Strategy & Innovation, Click Therapeutics
Kirsten Paulson, Executive Director, Global Regulatory Sciences, Medical Devices, Pfizer

Moderated by Kevin "Kip" Thomas, Principal Investigator, Laboratory for Human Neurobiology, Boston University

2:30 PM

NETWORKING COFFEE AND REFRESHMENT BREAK

Located in Foyer and Exhibition Area

3:00 PM

Reimbursement and Utilization - Evidence Generation: Discussions with Patients, Advocates, HCPs and Payers
3:00 PM

Integrating Decentralized Clinical Studies and Home-Based Learning Health Systems to Accelerate Evidence Generation

Apurv Soni, Assistant Professor in Medicine and Director, Program in Digital Medicine, UMass Chan Medical School

3:20 PM

Digital Therapeutics in Early Clinical Development

Laura Taraboanta, Associate Director, Clinical Strategy & Innovation, Click Therapeutics

3:35 PM

Quantifying the Value of Digital Endpoints in Clinical Trials

Sarah Valentine, Partnerships Lead, Life Sciences, Digital Medicine Society

3:50 PM

CONCLUDING PANEL DISCUSSION: Reimbursement and Utilization - Evidence Generation: Discussions with Caregivers, Access Leaders, HCPs and Payers

Adrianne Foote, Sr. Manager, Quality-Strategic Operations, Pfizer
Todd Miller, Director, Value & Access, Sanofi
Carrie Northcott, Head of Digital Sciences, Pfizer
Michael Pace, CEO, PalmHealthCo
Deepak Kumar, Assistant Professor, Physical Therapy and Rheumatology, Boston University

Moderated by Sarah Valentine, Partnerships Lead, Life Sciences, Digital Medicine Society
4:20 - 5:20 PM

NETWORKING RECEPTION


Speakers and Advisors
Carrie Northcott
Sr. Director, Head of Digital Sciences
PFIZER
Tim McCarthy
VP, Head of Digital Sciences & Translational Imaging
PFIZER
Xuemei Cai
Sr. Director, Head of Clinical Research
PFIZER

Jonathan Bruno
Director, Project Management
PFIZER
Bryan Hansen
Director, Data Science & Digital Health
J&J Innovative MEdicine
Kenzie Carlson
Implementation Manager, Digital Strategy
TAKEDA
Abhishek Pratap
Sr. Clinical Program Leader
BOEHRINGER INGELHEIM
Laura Taraboanta
Associate Director, Clinical Strategy & Innovation
CLICK THERAPEUTICS
Jeremy Wyatt
CEO
ACTIGRAPH
Charmaine Demanuele
Executive Director, Head of Quantitative Sciences
PFIZER
Gayle Wittenberg
VP Neuroscience, Data Science & Digital Health
J&J INNOVATIVE MEDICINE
Dzmitry Kaliukhovich
Principal Data Scientist, Data Science & Digital Health
J&J INNOVATIVE MEDICINE
Yiorgos Christakis
Senior Data Scientist
PFIZER
Lukas Adamowicz
Senior Data Scientist
PFIZER
Deepak Kumar
Assistant Professor, Physical Therapy and Rheumatology
BOSTON UNIVERSITY
Rinol Alaj
Head of Digital Health Technologies
REGENERON
Nikolay Manyakov
Senior Director, Data Science & Digital Health
J&J INnovative Medicine
Meenakshi Chatterjee
Principal Scientist, Data Science & Digital Health
J&J INNOVATIVE MEDICINE
Apurv Soni
Assistant Professor of Medicine
UMASS CHAN MEDICAL SCHOOL
Chris Economos
VP of Life Science
EKO HEALTH
Adrianne Foote
Sr. Manager, Quality-Strategic Operations
PFIZER
Sarah Valentine
Partnerships Lead, Life Sciences
DIGITAL MEDICINE SOCIETY
Andrea Coravos
CEO
HUMANFIRST
Michael Pace
CEO
PALMHEALTHCO
Maria Palombini
Global Practice Leader, Healthcare & Life Sciences
IEEE
Kevin "Kip" Thomas
Principal Investigator, Laboratory for Human Neurobiology
BOSTON UNIVERSITY
Ariel Dowling
Head of Sensing and Measurement
TAKEDA
Matteo Lai
CEO and Co-Founder
EMPATICA
Kirsten Paulson
Executive Director, Global Regulatory Sciences, Medical Devices
PFIZER
Caroline Currie
VP of Clinical
EKO HEALTH
Todd Miller
Director, Value & Access
SANOFI

Interested in Sponsorship & Exhibition Opportunities?
Location
Pfizer Innovation Research (PfIRe) Lab 
Cambridge, MA
The PfIRe Lab is a highly instrumented clinical research facility located in Cambridge, Massachusetts. Here, researchers use cutting-edge wearable and environmental sensors to develop and validate novel, patient-centric clinical endpoints, thereby potentially enabling a better understanding of a patient’s disease state and response to therapy.

Pfizer’s Digital Medicine & Translational Imaging Team recently unveiled this industry-leading facility in Cambridge, Massachusetts, designed to rapidly evaluate and validate novel technologies for potential use in clinical trials. In the PfIRe Lab, a multidisciplinary team of clinicians and researchers utilize state-of-the-art motion capture technologies, coupled with environmental and wearable sensors to develop new patient-centric clinical trial endpoints, enabling measures of physical function and activity outside of the traditional hospital and clinical settings.
 Join us at the
Digital Implementation Summit 2023!
The Premiere Event Connecting Clinical Trials to Clinical Use for Life Sciences

Processing Registration...